{
    "id": "5c6d441d7c78d69471000037",
    "question": "Does Eucommia ulmoides leaf extract ameliorates steatosis/fatty liver induced by high-fat diet?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the potential effects of Eucommia ulmoides leaf extract on steatosis/fatty liver induced by a high-fat diet. We can start by considering the known effects of Eucommia ulmoides on liver health. Eucommia ulmoides is a plant used in traditional Chinese medicine, and it has been shown to have antioxidant, anti-inflammatory, and hepatoprotective effects. These properties suggest that it may be beneficial in reducing liver damage and improving liver health. Next, we need to consider the effects of a high-fat diet on the liver. A high-fat diet is known to induce steatosis, a condition characterized by the accumulation of fat in liver cells. This can lead to liver damage and other health problems. Given the antioxidant and anti-inflammatory properties of Eucommia ulmoides, it is possible that it may help to reduce liver damage and ameliorate steatosis induced by a high-fat diet. Therefore, the answer to the question is that Eucommia ulmoides leaf extract may have a positive effect on steatosis/fatty liver induced by a high-fat diet.\", \"answer_choice\": \"A\"}}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_23959",
            "title": "InternalMed_Harrison",
            "content": "Diet and Exercise Lifestyle changes and dietary modification are the foundation for NAFLD treatment. Many studies indicate that lifestyle modification can improve serum aminotransferases and hepatic steatosis, with loss of at least 3\u20135% of body weight improving steatosis, but greater weight loss (up to 10%) necessary to improve steatohepatitis. The benefits of different dietary macronutrient contents (e.g., low-carbohydrate vs low-fat diets, saturated vs unsaturated fat diets) and different intensities of calorie restriction appear to be comparable. In adults with NAFLD, exercise regimens that improve fitness may be sufficient to reduce hepatic steatosis, but their impact on other aspects of liver histology remains unknown. Unfortunately, most NAFLD patients are unable to achieve sustained weight loss. Although pharmacologic therapies such as orlistat, topiramate, and phentermine to facilitate weight loss are available, their role in the treatment of NAFLD remains experimental."
        },
        {
            "id": "InternalMed_Harrison_27809",
            "title": "InternalMed_Harrison",
            "content": "increaSed Hepatic GlucoSe and lipid production In type 2 DM, insulin resistance in the liver reflects the failure of hyperinsulinemia to suppress gluconeogenesis, which results in fasting hyperglycemia and decreased glycogen storage by the liver in the postprandial state. Increased hepatic glucose production occurs early in the course of diabetes, although likely after the onset of insulin secretory abnormalities and insulin resistance in skeletal muscle. As a result of insulin resistance in adipose tissue, lipolysis and free fatty acid flux from adipocytes are increased, leading to increased lipid (very-low-density lipoprotein [VLDL] and triglyceride) synthesis in hepatocytes. This lipid storage or steatosis in the liver may lead to nonalcoholic fatty liver disease (Chap. 367e) and abnormal liver function tests. This is also responsible for the dyslipidemia found in type 2 DM (elevated triglycerides, reduced high-density lipoprotein [HDL], and increased small dense low-density"
        },
        {
            "id": "Pathology_Robbins_2249",
            "title": "Pathology_Robbins",
            "content": "High dietary intake of cholesterol and saturated fats (e.g., present in egg yolks, animal fats, and butter) raises plasma cholesterol levels. Conversely, diets low in cholesterol and/or containing higher ratios of polyunsaturated fats, lower plasma cholesterol levels. Omega-3 fatty acids (abundant in fish oils) are beneficial, whereas (trans)-unsaturated fats produced by artificial hydrogenation of polyunsaturated oils (used in baked goods and margarine) adversely affect cholesterol profiles. Exercise and moderate consumption of ethanol raise HDL levels, whereas obesity and smoking lower them. Statins are a widely used class of drugs that lower circulating cholesterol levels by inhibiting hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in hepatic cholesterol biosynthesis (Chapter 7)."
        },
        {
            "id": "Biochemistry_Lippincott_1316",
            "title": "Biochemistry_Lippinco",
            "content": "7.2. Which one of the following statements concerning dietary fat is correct? A. Coconut oil is rich in monounsaturated fats, and olive oil is rich in saturated fats. B. Fatty acids containing trans double bonds, unlike the naturally occurring cis isomers, raise high-density lipoprotein cholesterol levels. C. The polyunsaturated fatty acids linoleic and linolenic acids are required components. D. Triacylglycerols obtained from plants generally contain less unsaturated fatty acids than do those from animals. Correct answer = C. Humans are unable to make linoleic and linolenic fatty acids. Consequently, these fatty acids are essential in the diet. Coconut oil is rich in saturated fats, and olive oil is rich in monounsaturated fats. Trans fatty acids raise plasma levels of low-density lipoprotein cholesterol, not high-density lipoprotein cholesterol. Triacylglycerols obtained from plants generally contain more unsaturated fatty acids than do those from animals."
        },
        {
            "id": "Biochemistry_Lippincott_1196",
            "title": "Biochemistry_Lippinco",
            "content": "result is chronic, low-grade inflammation. One effect of insulin resistance is increased lipolysis and production of FFA (see Fig. 25.9). FFA availability decreases use of glucose, contributing to hyperglycemia, and increases ectopic deposition of TAG in liver (hepatic steatosis). [Note: Steatosis results in nonalcoholic fatty liver disease (NAFLD). If accompanied by inflammation, a more serious condition, nonalcoholic steatohepatitis (NASH), can develop.] FFA also have a proinflammatory effect. In the long term, FFA impair insulin signaling. [Note: Adiponectin increases FA \u03b2-oxidation (see p. 349). Consequently, a decrease in this adipocyte protein contributes to FFA availability.]"
        },
        {
            "id": "InternalMed_Harrison_5210",
            "title": "InternalMed_Harrison",
            "content": "Conventionally raised apoE-deficient mice develop a less severe form of atherosclerosis than their germ-free counterparts when fed a high-fiber diet. This protective effect of the microbiota is obviated when animals are fed a diet low in fiber and high in simple sugars and fat. A number of the beneficial effects attributed to diets with high proportional representation of whole grains, fruits, and vegetables are thought to be mediated by end products of microbial metabolism of dietary compounds, including short-chain fatty acids and metabolites derived from flavonoids. Conversely, microbes can convert otherwise harmless dietary compounds into metabolites that increase risk for cardiovascular disease. Studies of mice and human volunteers have revealed that gut microbiota metabolism of dietary L-carnitine, which is present in large amounts in red meat, yields trimethylamineN-oxide, which can accelerate atherosclerosis in mice by suppressing reverse cholesterol transport."
        },
        {
            "id": "Pharmacology_Katzung_3906",
            "title": "Pharmacology_Katzung",
            "content": "Skeletal muscle Fatty acid oxidation Lipoprotein lipase Endothelium Liver Apo Clll synthesis Apo Al and Apo AII synthesis Fatty acids VLDL, Chylomicron Transcription of LPL vessels Hydrolysis of VLDL and chylomicron triglycerides FIGURE 35\u20134 Hepatic and peripheral effects of fibrates. These effects are mediated by activation of peroxisome proliferator-activated receptor-\u03b1, which decreases the secretion of VLDL and increases its peripheral metabolism. LPL, lipoprotein lipase; VLDL, very-low-density lipoproteins. Niacin (but not niacinamide) decreases triglycerides and LDL levels, and Lp(a) in most patients. It often increases HDL levels significantly. Historically, combination therapy including niacin has been associated with regression of atherosclerotic coronary lesions in three angiographic trials and with extension of lifespan in one large trial in which patients received niacin alone."
        },
        {
            "id": "Biochemistry_Lippincott_1266",
            "title": "Biochemistry_Lippinco",
            "content": "2. Monounsaturated fats: TAG containing primarily fatty acids with one double bond are referred to as monounsaturated fats. Monounsaturated fatty acids (MUFA) are generally obtained from plant-based oils. When substituted for saturated fatty acids in the diet, MUFA lower both total plasma cholesterol and LDL-C and maintain or increase HDL-C. This ability of MUFA to favorably modify lipoprotein levels may explain, in part, the observation that Mediterranean cultures, with diets rich in olive oil (high in monounsaturated oleic acid), show a low incidence of CHD. [Note: Although there is no AMDR for MUFA, a common recommendation is 10%\u201320% of caloric intake.] a. The Mediterranean diet: The Mediterranean diet is an example of a diet rich in MUFA (from olive oil) and polyunsaturated fatty acids or PUFA (from fish oils, plant oils, and some nuts) but low in saturated fat. For example, Figure 27.11 shows the composition of the Mediterranean diet in comparison with both a Western diet similar"
        },
        {
            "id": "Obstentrics_Williams_6600",
            "title": "Obstentrics_Williams",
            "content": "bThose with normal values while taking medications are considered to meet these criteria. Data from Alberti, 2009. Generally speaking, visceral adiposity correlates with hepatic fat content (Cornier, 201l). With obesity, excessive fat accumulates in the liver-hepatic steatosis, which is also called nonalcoholic fatty liver disease (NAFLD). In persons with the metabolic syndrome, steatosis can progress to nonalcoholic steatohepatitis (NASH) and cirrhosis, as well as hepatocellular carcinoma. Indeed, one fourth of chronic liver disease cases worldwide are caused by NAFLD (Younossi, 2016). \\10reover, NAFLD is strongly associated with both fatal and nonfatal cardiovascular disease (T argher, 2016)."
        },
        {
            "id": "InternalMed_Harrison_28314",
            "title": "InternalMed_Harrison",
            "content": "Diets restricted in saturated fats (<7% of calories) and trans-fats (as few as possible) should be applied aggressively. Although less evidence exists, dietary cholesterol should also be restricted. If LDL cholesterol remains elevated, pharmacologic intervention is needed. Treatment with statins, which lower LDL cholesterol by 15\u201360%, is evidence based and is the first-choice medication intervention. Of note, for each doubling of the statin dose, LDL cholesterol is further lowered by only ~6%. Hepatotoxicity (more than a threefold increase in hepatic aminotransferases) is rare, and myopathy is seen in ~10% of patients. The cholesterol absorption inhibitor ezetimibe is well tolerated and should be the second- choice medication intervention. Ezetimibe typically reduces LDL cholesterol by 15\u201320%. The bile acid sequestrants cholestyramine, colestipol, and colesevalam may be more effective than ezetimibe but, because they can increase triglyceride levels, must be used with caution in"
        },
        {
            "id": "InternalMed_Harrison_27684",
            "title": "InternalMed_Harrison",
            "content": "Hepatobiliary Disease Obesity is frequently associated with nonalcoholic fatty liver disease (NAFLD), and this association represents one of the most common causes of liver disease in industrialized countries. The hepatic fatty infiltration of NAFLD progresses in a subset to inflammatory nonalcoholic steatohepatitis (NASH) and more rarely to cirrhosis and hepatocellular carcinoma. Steatosis typically improves following weight loss, secondary to diet or bariatric surgery. The mechanism for the association remains unclear. Obesity is associated with enhanced biliary secretion of cholesterol, supersaturation of bile, and a higher incidence of gallstones, particularly cholesterol gallstones (Chap. 369). A person 50% above IBW has about a sixfold increased incidence of symptomatic gallstones. Paradoxically, fasting increases supersaturation of bile by decreasing the phospholipid component. Fasting-induced cholecystitis is a complication of extreme diets."
        },
        {
            "id": "Pharmacology_Katzung_7119",
            "title": "Pharmacology_Katzung",
            "content": "1. Liver disease\u2014In animal models, milk thistle purportedly limits hepatic injury associated with a variety of toxins, including Amanita mushrooms, galactosamine, carbon tetrachloride, acetaminophen, radiation, cold ischemia, and ethanol. In vitro studies and some in vivo studies indicate that silymarin reduces lipid per-oxidation, scavenges free radicals, and enhances glutathione and superoxide dismutase levels. This may contribute to membrane stabilization and reduce toxin entry."
        },
        {
            "id": "Biochemistry_Lippincott_507",
            "title": "Biochemistry_Lippinco",
            "content": "Thus, the health-promoting effects of dietary fruits and vegetables likely reflect a complex interaction among many naturally occurring compounds, which has not been duplicated by consumption of isolated antioxidant compounds."
        },
        {
            "id": "InternalMed_Harrison_27676",
            "title": "InternalMed_Harrison",
            "content": "Insulin Resistance and Type 2 Diabetes Mellitus Hyperinsulinemia and insulin resistance are pervasive features of obesity, increasing with weight gain and diminishing with weight loss (Chap. 422). Insulin resistance is more strongly linked to intraabdominal fat than to fat in other depots. Molecular links between obesity and insulin resistance in fat, muscle, and liver have been sought for many years. Major factors include: (1) insulin itself, by inducing receptor downregulation; (2) free fatty acids that are increased and capable of impairing insulin action; (3) intracellular lipid accumulation; and (4) several circulating peptides produced by adipocytes, including the cytokines TNF-\u03b1 and IL-6, RBP4, and the \u201cadipokines\u201d adiponectin and resistin, which have altered expression in obese adipocytes and can modify insulin action. Additional mechanisms are obesity-linked inflammation, including infiltration of macrophages into tissues including fat, and induction of the endoplasmic"
        },
        {
            "id": "InternalMed_Harrison_23671",
            "title": "InternalMed_Harrison",
            "content": "histologic lesions following Jin Bu Huan use: focal hepatocellular necrosis, mixed mononuclear portal tract infiltration, coagulative necrosis, apoptotic hepatocyte degeneration, tissue eosinophilia, and microvesicular steatosis. Megadoses of vitamin A can injure the liver, as can pyrrolizidine alkaloids, which often contaminate Chinese herbal preparations and can cause a venoocclusive injury leading to sinusoidal hepatic vein obstruction. Because some alternative medicines induce toxicity via active metabolites, alcohol and drugs that stimulate cytochrome P450 enzymes may enhance the toxicity of some of these products. Conversely, some alternative medicines also stimulate cytochrome P450 and may result in or amplify the toxicity of recognized drug hepatotoxins. Given the widespread use of such poorly defined herbal preparations, hepatotoxicity is likely to be encountered with increasing frequency; therefore, a drug history in patients with acute and chronic liver disease should"
        },
        {
            "id": "Pathoma_Husain_398",
            "title": "Pathoma_Husain",
            "content": "2. Weight loss, low muscle mass, and polyphagia-Unopposed glucagon leads to gluconeogenesis, glycogenolysis and lipolysis, which further exacerbates hyperglycemia. 3. Polyuria, polydipsia, and glycosuria-Hyperglycemia exceeds renal ability to resorb glucose; excess filtered glucose leads to osmotic diuresis. 4. Treatment involves lifelong insulin. D. Risk for diabetic ketoacidosis 1. 2. Often arises with stress (e.g., infection); epinephrine stimulates glucagon secretion increasing lipolysis (along with gluconeogenesis and glycogenolysis). i. Increased lipolysis leads to increased free fatty acids (FFAs). ii. Liver converts FFAs to ketone bodies (~-hydroxybutyric acid and acetoacetic acid). 3. Results in hyperglycemia (> 300 mg/dL), anion gap metabolic acidosis, and hyperkalemia 4. Presents with Kussmaul respirations, dehydration, nausea, vomiting, mental status changes, and fruity smelling breath (due to acetone) 5."
        },
        {
            "id": "InternalMed_Harrison_23943",
            "title": "InternalMed_Harrison",
            "content": "Obese adipose depots also produce excessive soluble factors (adipokines) that inhibit tissue insulin sensitivity. Insulin resistance promotes hyperglycemia. This drives the pancreas to produce more insulin to maintain glucose homeostasis. However, hyperinsulinemia also promotes lipid uptake, fat synthesis, and fat storage. The net result is hepatic triglyceride accumulation (i.e., steatosis)."
        },
        {
            "id": "InternalMed_Harrison_23942",
            "title": "InternalMed_Harrison",
            "content": "The mechanisms underlying the pathogenesis and progression of NAFLD are not entirely clear. The best-understood mechanisms pertain to hepatic steatosis. This is proven to result when hepatocyte mechanisms for triglyceride synthesis (e.g., lipid uptake and de novo lipogenesis) overwhelm mechanisms for triglyceride disposal (e.g., degradative metabolism and lipoprotein export), leading to accumulation of fat (i.e., triglyceride) within hepatocytes. Obesity stimulates hepatocyte triglyceride accumulation by altering the intestinal microbiota to enhance both energy harvest from dietary sources and intestinal permeability. Reduced intestinal barrier function increases hepatic exposure to gut-derived products, which stimulate liver cells to generate inflammatory mediators that inhibit insulin actions. Obese adipose depots also produce excessive soluble factors (adipokines) that inhibit tissue insulin sensitivity. Insulin resistance promotes hyperglycemia. This drives the pancreas to produce"
        },
        {
            "id": "Pathology_Robbins_3943",
            "title": "Pathology_Robbins",
            "content": "NAFLD is a common condition in which fatty liver disease develops in individuals who do not drink alcohol. The liver can show any of the three types of changes discussed earlier (steatosis, steatohepatitis, and cirrhosis), though on average inflammation is less prominent than in alcoholic liver disease. The term nonalcoholic steatohepatitis (NASH) is used to describe overt clinical features of liver injury, such as elevated transaminases, and the histologic features of hepatitis already discussed. NAFLD is consistently associated with insulin resistance and the metabolic syndrome (Chapter 8). Other commonly associated abnormalities are as follows: Type 2 diabetes (or family history of the condition) Obesity, primarily central obesity (body mass index >30 kg/m2 in whites and >25 kg/m2 in Asians) Dyslipidemia (hypertriglyceridemia, low high-density lipoprotein cholesterol, high low-density lipoprotein cholesterol)"
        },
        {
            "id": "InternalMed_Harrison_23670",
            "title": "InternalMed_Harrison",
            "content": "Herbal medications that are of scientifically unproven efficacy and that lack prospective safety oversight by regulatory agencies currently account for more than 20% of drug-induced liver injury in the United States. Besides anabolic steroids, the most common category of dietary or herbal products is weight loss agents. Included among the herbal remedies associated with toxic hepatitis are Jin Bu Huan, xiao-chai-hutang, germander, chaparral, senna, mistletoe, skullcap, gentian, comfrey (containing pyrrolizidine alkaloids), ma huang, bee pollen, valerian root, pennyroyal oil, kava, celandine, Impila (Callilepis laureola), LipoKinetix, Hydroxycut, herbal nutritional supplements, and herbal teas containing Camellia sinensis (green tea extract). Well characterized are the acute hepatitis-like histologic lesions following Jin Bu Huan use: focal hepatocellular necrosis, mixed mononuclear portal tract infiltration, coagulative necrosis, apoptotic hepatocyte degeneration, tissue eosinophilia,"
        },
        {
            "id": "Pharmacology_Katzung_2005",
            "title": "Pharmacology_Katzung",
            "content": "different dose-response relationships. There is an abundance of epidemiologic data relating diets high in fatty fish to a reduction in the incidence of myocardial infarction and sudden cardiac death, although there is more ambiguity about stroke. However, such epidemiologic data may be confounded by concurrent reduction in saturated fats and inclusion of other elements of a \u201chealthy\u201d lifestyle, raising questions about the cardiovascular benefit of dietary omega-3 fatty acids. Nevertheless, data from prospective randomized trials suggest that such dietary interventions may reduce the incidence of sudden death while experiments in vitro suggest that fish oils protect against experimentally induced arrhythmogenesis, platelet aggregation, vasomotor spasm, and dyslipidemias."
        },
        {
            "id": "InternalMed_Harrison_23918",
            "title": "InternalMed_Harrison",
            "content": "alcohol consumption to understand that one beer, four ounces of wine, or one ounce of 80% spirits all contain \u223c12 g of alcohol. The threshold for developing alcoholic liver disease is higher in men, while women are at increased risk for developing similar degrees of liver injury by consuming significantly less. Gender-dependent differences result from poorly understood effects of estrogen, proportion of body fat, and the gastric metabolism of alcohol. Obesity, a high-fat diet, and the protective effect of coffee have been postulated to play a part in the development of the pathogenic process."
        },
        {
            "id": "InternalMed_Harrison_23669",
            "title": "InternalMed_Harrison",
            "content": "ALTERNATIVE AND COMPLEMENTARY MEDICINES (IDIOSYNCRATIC HEPATITIS, STEATOSIS)"
        },
        {
            "id": "Biochemistry_Lippincott_1311",
            "title": "Biochemistry_Lippinco",
            "content": "result in increased risk for coronary heart disease (CHD). In contrast, elevated levels of cholesterol in high-density lipoproteins (HDL-C) have been associated with a decreased risk for CHD. Dietary or drug treatment of hypercholesterolemia is effective in decreasing LDL-C, increasing HDLC, and reducing the risk for CHD. Consumption of saturated fats is strongly associated with high levels of total plasma and LDL-C. When substituted for saturated fatty acids in the diet, monounsaturated fats lower both total plasma cholesterol and LDL-C but maintain or increase HDL-C. Consumption of fats containing \u03c9-6 polyunsaturated fatty acids lowers plasma LDL-C, but HDL-C, which protects against CHD, is also lowered. Dietary \u03c9-3 polyunsaturated fats suppress cardiac arrhythmias and reduce plasma triacylglycerols, decrease the tendency for thrombosis, and substantially reduce the risk of cardiovascular mortality. Carbohydrates provide energy and fiber to the diet. When they are consumed as part"
        },
        {
            "id": "Biochemistry_Lippincott_1264",
            "title": "Biochemistry_Lippinco",
            "content": "2. Benefits of lowering plasma cholesterol: Dietary or drug treatment of hypercholesterolemia has been shown to be effective in decreasing LDLC, increasing HDL-C, and reducing the risk for cardiovascular events. The diet-induced changes in plasma cholesterol concentrations are modest, typically 10%\u201320%, whereas treatment with statin drugs decreases plasma cholesterol by 30%\u201360% (see p. 224). [Note: Dietary and drug treatment can also lower TAG.] B. Dietary fats and plasma lipids TAG are quantitatively the most important class of dietary fats. The influence of TAG on blood lipids is determined by the chemical nature of their constituent fatty acids. The absence or presence and number of double bonds (saturated versus mono-and polyunsaturated), the location of the double bonds (\u03c9-6 versus \u03c9-3), and the cis versus trans configuration of the unsaturated fatty acids are the most important structural features that influence blood lipids."
        },
        {
            "id": "Biochemistry_Lippincott_1861",
            "title": "Biochemistry_Lippinco",
            "content": "C. In response to secretin, the exocrine pancreas secretes protons to lower the pH in the intestinal lumen. D. Pancreatitis may also be seen in individuals with hypercholesterolemia. TQ1. A. What effect does the rise in cytosolic NADH seen with ethanol metabolism have on glycolysis? Hint: What coenzyme is required in glycolysis? B. How does this relate to the fatty liver (hepatic steatosis) commonly seen in alcohol-dependent individuals? TQ2. Why might individuals with a history of gouty attacks be advised to reduce their consumption of ethanol? TQ3. Why might prothrombin time be affected in alcohol-dependent individuals? TQ4. Folate and vitamin B12 deficiencies cause a macrocytic anemia that may be seen in those with alcoholism. Why is it advisable to measure vitamin B12 levels before supplementing with folate in an individual with macrocytic anemia? Case 1: Answers to Review Questions"
        },
        {
            "id": "InternalMed_Harrison_23964",
            "title": "InternalMed_Harrison",
            "content": "in 43% of patients in the vitamin E group (p = .001 vs placebo), 34% in the pioglitazone group (p = .04 vs placebo), and 19% in the placebo group. Vitamin E also improved NASH histology in pediatric patients with NASH (TONIC trial). However, a recent population-based study suggested that chronic vitamin E therapy may increase the risk for cardiovascular mortality. Thus, vitamin E should only be considered as a first-line pharmacotherapy for nondiabetic NASH patients. Also, given its potentially negative effects on cardiovascular health, caution should be exercised until the risk-to-benefit ratio and long-term therapeutic efficacy of vitamin E are better defined. Ursodeoxycholic acid (a bile acid that improves certain cholestatic liver diseases) and betaine (metabolite of choline that raises SAM levels and decreases cellular oxidative damage) offer no histologic benefit over placebo in patients with NASH. Experimental evidence to support the use of omega-3 fatty acids in NAFLD exists;"
        },
        {
            "id": "InternalMed_Harrison_5573",
            "title": "InternalMed_Harrison",
            "content": "Repeated fasting and eating cycles may circumvent the negative side effects of sustained caloric restriction. This strategy may even yield effects despite extreme overeating during the nonfasting periods. In a spectacular experiment, mice fed a high-fat diet in a time-restricted manner, i.e., with regular fasting breaks, showed reduced inflammation markers and no fatty liver and were slim in comparison to mice with equivalent total calorie consumption but ad libitum. From an evolutionary point of view, this kind of feeding pattern may reflect mammalian adaptation to food availability: overeating in times of nutrient availability (e.g., after a hunting success) and starvation in between. This is how some indigenous peoples who have avoided Western lifestyles live today; those who have been investigated show limited signs of age-induced diseases such as cancer, neurodegeneration, diabetes, cardiovascular disease, and hypertension."
        },
        {
            "id": "Biochemistry_Lippincott_1247",
            "title": "Biochemistry_Lippinco",
            "content": "The elevated circulating free fatty acids characteristic of obesity are carried to the liver and converted to TAG. The TAG are released as components of very-low-density lipoproteins, resulting in elevated plasma TAG levels, or are stored in the liver, resulting in hepatic steatosis."
        },
        {
            "id": "Pathology_Robbins_2060",
            "title": "Pathology_Robbins",
            "content": "Currently, one of the most important and controversial issues is the contribution of diet to atherogenesis. The central question is whether dietary modification\u2014 specifically, reduction in the consumption of foods high in cholesterol and saturated animal fats (e.g., eggs, butter, beef)\u2014can reduce serum cholesterol levels and prevent or retard the development of atherosclerosis (of most importance, coronary heart disease) in those with no previous episode of cardiovascular disease. This is called \u201cprimary prevention\u201d. We know some but not all the answers. The average adult in the United States consumes a large amount of fat and cholesterol daily, with a ratio of saturated fatty acids to polyunsaturated fatty acids of about 3:1. Lowering the level of saturates to the level of the polyunsaturates causes a 10% to 15% reduction in serum cholesterol within a few weeks. Vegetable oils (e.g., corn and safflower oils) and fish oils contain polyunsaturated fatty acids and are good sources of"
        },
        {
            "id": "Biochemistry_Lippincott_1900",
            "title": "Biochemistry_Lippinco",
            "content": "B. Glyceraldehyde 3-phosphate from glycolysis is converted to glycerol 3phosphate, the initial acceptor of FA in triacylglycerol (TAG) synthesis (see figure at right). FA are available because of increased synthesis (from acetyl CoA, which is increased as a result of both increased production from the acetate product of acetaldehyde oxidation and decreased use in the TCA cycle), increased availability from lipolysis in adipose tissue, and decreased degradation. The TAG produced in the liver accumulate (due, in part, to decreased production of very-low-density lipoproteins) and cause fatty liver (steatosis). Hepatic steatosis is an early (and reversible) stage in alcohol-related liver disease. Subsequent stages are alcohol-related hepatitis (sometimes reversible) and cirrhosis (irreversible)."
        },
        {
            "id": "InternalMed_Harrison_23920",
            "title": "InternalMed_Harrison",
            "content": "The pathogenesis of alcoholic liver injury is unclear. The present conceptual foundation is that alcohol acts as a direct hepatotoxin and that malnutrition does not have a major role. Ingestion of alcohol initiates an inflammatory cascade by its metabolism to acetaldehyde, resulting in a variety of metabolic responses. Steatosis from lipogenesis, fatty acid synthesis, and depression of fatty acid oxidation appears secondary to effects on sterol regulatory transcription factor and peroxisome proliferator-activated receptor \u03b1 (PPAR-\u03b1). Intestinal-derived endotoxin initiates a pathogenic process through toll-like receptor 4 and tumor necrosis factor \u03b1 (TNF-\u03b1) that facilitates hepatocyte apoptosis and necrosis. The cell injury and endotoxin release initiated by ethanol and its metabolites also activate innate and adaptive immunity pathways releasing proinflammatory cytokines (e.g., TNF-\u03b1), chemokines, and proliferation of T and B cells. The production of toxic protein-aldehyde adducts,"
        }
    ],
    "scores": [
        0.03510478497880073,
        0.024260434194209028,
        0.021321706877797393,
        0.020414673046251993,
        0.020170696700218475,
        0.020133288530465948,
        0.018812930577636458,
        0.018779756656674307,
        0.017998385794995964,
        0.01798790306809018,
        0.01793400286944046,
        0.01736732259988074,
        0.017322718561108653,
        0.01721096096096096,
        0.016955114675671873,
        0.01668520578420467,
        0.01666782415445517,
        0.01655719759168035,
        0.016530054644808743,
        0.016479937467430955,
        0.016214449166394244,
        0.016023626995098655,
        0.015839300886029858,
        0.01546451914098973,
        0.015226956924502084,
        0.015152384778740743,
        0.015148247978436658,
        0.015061238000662032,
        0.014946182588812671,
        0.014908130707448564,
        0.014894795127353266,
        0.01473922902494331
    ]
}